Opocrin Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FERRIC OXYHYDROXIDE WITH SUCROSE, with a corresponding US DMF Number 33020.
Remarkably, this DMF maintains an Active status since its submission on August 09, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 26, 2019, and payment made on February 19, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II